COVID-19 adverse outcome pathway (Q89776198)
Jump to navigation
Jump to search
Experimental pathway to investigate overlap of Covid-19 downstream effects and adverse outcome pathways related to lung injury.
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | COVID-19 adverse outcome pathway |
Experimental pathway to investigate overlap of Covid-19 downstream effects and adverse outcome pathways related to lung injury. |
Statements
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference